Literature DB >> 718348

Familial hyperpotassemia and hypertension accompanied by normal plasma aldosterone levels: possible hereditary cell membrane defect.

Z Farfel, A Iaina, T Rosenthal, U Waks, S Shibolet, J Gafni.   

Abstract

Hypertension and hyperpotassemia that were accompanied by normal plasma aldosterone and low renin levels and were responsive to chlorothiazide administration were found in a 29-year-old patient and two decades later in his 21-year-old son. Their renal function is normal, including response to sodium sulfate, mannitol, and aldosterone infusions. Adrenal insufficiency was excluded. The renin-aldosterone system was proved intact by physiological and pharmacologic stress and angiotensin-II infusion. Also normal were values for blood counts, blood volumes, and erythrocyte and exchangeable body potassium. The postulation of a defective cell membrane impeding potassium influx is supported by the failure of glucose and insulin infusions to substantially reduce hyperpotassemia. In the context of a hereditary disorder (the pedigree, compatible with autosomal dominant inheritance, includes five affected in two generations), hypertension is a second phenotypic character of a single defective pleiotropic gene although its pathogenesis remains unclear.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 718348

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  17 in total

1.  Disease-causing mutant WNK4 increases paracellular chloride permeability and phosphorylates claudins.

Authors:  Kozue Yamauchi; Tatemitsu Rai; Katsuki Kobayashi; Eisei Sohara; Tatsunori Suzuki; Tomohiro Itoh; Shin Suda; Atsushi Hayama; Sei Sasaki; Shinichi Uchida
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-19       Impact factor: 11.205

Review 2.  WNK kinases and renal sodium transport in health and disease: an integrated view.

Authors:  James A McCormick; Chao-Ling Yang; David H Ellison
Journal:  Hypertension       Date:  2008-01-22       Impact factor: 10.190

Review 3.  The WNKs: atypical protein kinases with pleiotropic actions.

Authors:  James A McCormick; David H Ellison
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

4.  [Primary hypoaldosteronism, pseudo-hypoaldosteronism and distal tubular acidosis].

Authors:  D Klaus
Journal:  Klin Wochenschr       Date:  1984-08-16

Review 5.  Distal potassium handling based on flow modulation of maxi-K channel activity.

Authors:  Aylin R Rodan; Chou-Long Huang
Journal:  Curr Opin Nephrol Hypertens       Date:  2009-07       Impact factor: 2.894

Review 6.  Type II pseudohypoaldosteronism. Report of a case and review of the literature.

Authors:  S Muhammad; Z M Mamish; J R Tucci
Journal:  J Endocrinol Invest       Date:  1994-06       Impact factor: 4.256

7.  Mutations in the nervous system--specific HSN2 exon of WNK1 cause hereditary sensory neuropathy type II.

Authors:  Masoud Shekarabi; Nathalie Girard; Jean-Baptiste Rivière; Patrick Dion; Martin Houle; André Toulouse; Ronald G Lafrenière; Freya Vercauteren; Pascale Hince; Janet Laganiere; Daniel Rochefort; Laurence Faivre; Mark Samuels; Guy A Rouleau
Journal:  J Clin Invest       Date:  2008-07       Impact factor: 14.808

8.  A patient with pseudohypoaldosteronism type II caused by a novel mutation in WNK4 gene.

Authors:  Hui Gong; Zhengyi Tang; Yang Yang; Lihao Sun; Wei Zhang; Weiqing Wang; Bin Cui; Guang Ning
Journal:  Endocrine       Date:  2008-06       Impact factor: 3.633

Review 9.  Metabolites and Hypertension: Insights into Hypertension as a Metabolic Disorder: 2019 Harriet Dustan Award.

Authors:  Saroj Chakraborty; Juthika Mandal; Tao Yang; Xi Cheng; Ji-Youn Yeo; Cameron G McCarthy; Camilla F Wenceslau; Lauren G Koch; Jennifer W Hill; Matam Vijay-Kumar; Bina Joe
Journal:  Hypertension       Date:  2020-04-27       Impact factor: 10.190

10.  Cell-specific regulation of L-WNK1 by dietary K.

Authors:  Tennille N Webb; Rolando Carrisoza-Gaytan; Nicolas Montalbetti; Anna Rued; Ankita Roy; Alexandra M Socovich; Arohan R Subramanya; Lisa M Satlin; Thomas R Kleyman; Marcelo D Carattino
Journal:  Am J Physiol Renal Physiol       Date:  2015-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.